Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
12.12
+0.92 (8.21%)
May 1, 2026, 10:15 AM EDT - Market open
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $962.69 million as of May 1, 2026. Its market cap has increased by 189.82% in one year.
Market Cap
962.69M
Enterprise Value
1.35B
1-Year Change
189.82%
Ranking
Category
Stock Price
$12.12
Market Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $962.69M, an increase of 82.63%. That is a compound annual growth rate of 9.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 889.62M | -24.62% |
| Dec 31, 2025 | 1.18B | 112.56% |
| Dec 31, 2024 | 555.22M | 6.22% |
| Dec 29, 2023 | 522.72M | 13.23% |
| Dec 30, 2022 | 461.63M | -22.48% |
| Dec 31, 2021 | 595.53M | -36.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fortrea Holdings | 987.36M |
| Design Therapeutics | 973.81M |
| Geron | 967.76M |
| Annexon | 957.17M |
| ORIC Pharmaceuticals | 947.38M |
| Maravai LifeSciences Holdings | 894.59M |
| Sana Biotechnology | 891.72M |
| CytomX Therapeutics | 881.66M |